AST
|
NAFLD
|
Genotype (additive model, 0/1/2)
|
10.165
|
2.606
|
0.00013
|
| |
Age (year)
|
-0.162
|
0.153
|
0.29
|
| |
Gender (Man/Women, 1/0)
|
-4.967
|
4.335
|
0.25
|
| |
BMI (kg/m2)
|
0.711
|
0.380
|
0.063
|
|
Control
|
Genotype (additive model, 0/1/2)
|
0.567
|
0.466
|
0.23
|
| |
Age (year)
|
0.176
|
0.022
|
4.2 × 10-14
|
| |
Gender (Man/Women, 1/0)
|
0.226
|
0.775
|
0.77
|
| |
BMI (kg/m2)
|
0.120
|
0.167
|
0.47
|
ALT
|
NAFLD
|
Genotype (additive model, 0/1/2)
|
18.977
|
4.171
|
9.1 × 10-6
|
| |
Age (year)
|
-1.125
|
0.244
|
7.1 × 10-6
|
| |
Gender (Man/Women, 1/0)
|
7.571
|
6.938
|
0.28
|
| |
BMI (kg/m2)
|
0.991
|
0.608
|
0.10
|
|
Control
|
Genotype (additive model, 0/1/2)
|
0.417
|
0.477
|
0.38
|
| |
Age (year)
|
0.120
|
0.023
|
2.5 × 10-7
|
| |
Gender (Man/Women, 1/0)
|
2.131
|
0.793
|
0.0076
|
| |
BMI (kg/m2)
|
0.370
|
0.171
|
0.031
|
Triglycerides
|
NAFLD
|
Genotype (additive model, 0/1/2)
|
-0.050
|
0.017
|
0.0035
|
| |
Age (year)
|
-0.003
|
0.001
|
0.0051
|
| |
Gender (Man/Women, 1/0)
|
0.102
|
0.023
|
0.00038
|
| |
BMI (kg/m2)
|
-0.001
|
0.002
|
0.66
|
Ferritin
|
NAFLD
|
Genotype (additive model, 0/1/2)
|
0.107
|
0.043
|
0.014
|
| |
Age (year)
|
0.005
|
0.002
|
0.056
|
| |
Gender (Man/Women, 1/0)
|
0.298
|
0.069
|
2.9 × 10-5
|
| |
BMI (kg/m2)
|
0.009
|
0.006
|
0.11
|
Hyaluronic acid
|
NAFLD
|
Genotype (additive model, 0/1/2)
|
0.023
|
0.036
|
0.52
|
| |
Age (year)
|
0.016
|
0.002
|
1.6 × 10-12
|
| |
Gender (Man/Women, 1/0)
|
-0.010
|
0.059
|
0.87
|
| |
BMI (kg/m2)
|
0.014
|
0.005
|
0.0047
|
Steatosis grade
|
NAFLD
|
Genotype (additive model, 0/1/2)
|
0.041
|
0.059
|
0.48
|
| |
Age (year)
|
-0.010
|
0.003
|
0.0037
|
| |
Gender (Man/Women, 1/0)
|
-0.106
|
0.098
|
0.28
|
| |
BMI (kg/m2)
|
0.022
|
0.009
|
0.010
|
Fibrosis stage
|
NAFLD
|
Genotype (additive model, 0/1/2)
|
0.211
|
0.082
|
0.011
|
| |
Age (year)
|
0.013
|
0.005
|
0.0058
|
| |
Gender (Man/Women, 1/0)
|
0.184
|
0.136
|
0.18
|
| |
BMI (kg/m2)
|
0.046
|
0.012
|
0.00016
|